• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Oridion still can’t shake the Physio-Control blues

Oridion still can’t shake the Physio-Control blues

August 24, 2009 By MassDevice staff

Sometimes it’s the company you keep.

For Oridion, which has its U.S. base of operations in Needham, Mass., that company would be Physio-Control Inc., one of its distribution partners.

Oridion, which makes capnography monitors to measure the amount of CO2 in a patient’s breath, took a 72 percent hit to its bottom line during the first six months of 2009 due to continuing problems with the distributor.

Oridion sells many of its products through OEM and and private-label agreements with companies like Siemens and Philips Medical Systems.

But the distribution deal with Physio-Control, a division of Minnesota-based medical device goliath Medtronic continues to drag down the company’s bottom line.

In January of 2007, Physio-Control suspended shipments of its LIFEPAK defibrillators after a Food & Drug Administration inspection of its Washington state plant. Those findings led to an injunction being filed in U.S. District Court in Seattle in April last year, with the federal watchdog contending that Physio-Control failed to address 11 violations flagged in previous inspections.

In the resulting settlement, Physio-Control was ordered to halt sales until it could clear up the issues with the FDA.

The stoppage has had a profound effect on Oridion’s bottom line. The company logged virtually no sales through Physio-Control for the first six months of the year; by comparison, the agreement produced about $3.4 million in sales during the same period last year. Officials said they’re hopeful that revenues through Physio-Control will rebound in the third and fourth quarter of this year.

For the second quarter, the company reported a $588,000 profit on $9.7 million in sales, compared to $1.9 million on $10.7 million in sales for the same period last year.

For the six-month period ended June 30, Oridion reported $902,000 in profit on $19 million in sales, compared to $3.2 million on $22 million in sales.

The company also issued guidance for the rest of the year, speculating that sales would decline overall by about 5 percent.

Filed Under: Business/Financial News, Diagnostics, Patient Monitoring

More recent news

  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy